MustGrow Biologics Corp.

MustGrow Biologics Corp.

MGRO · V · Basic Materials / Agricultural Inputs

0.365CAD-0.04 (-8.75%)

Price History

Full chart

Market Stats

Previous Close0.40
Open0.375
Day Range0.35 – 0.375
52-Week Range0.29 – 0.94
Volume30.07K
Market Cap29.57M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.08
Dividend Yield0.00%
Beta0.56
50-Day Avg0.4142
200-Day Avg0.5194

About

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. It also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, the company is developing TerraSante, an organic soil amendment and biofertility technology. Further, it sells biostimulants, micronutrients, nitrogen stabilizers, and foliars. Additionally, the company offers biological and regenerative agriculture solutions to support sustainable farming. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

Company Details

  • SectorBasic Materials
  • IndustryAgricultural Inputs
  • CEOMr. Corey J. Giasson B.Sc., MBA
  • Employees0
  • Headquarters201 1st Avenue South, Saskatoon, SK, Canada, S7K 1J5, Canada
  • Websitehttps://mustgrow.ca

Leadership

  • Mr. Corey J. Giasson B.Sc., MBAPresident, CEO & Director · b. 1978
  • Mr. Todd L. Lahti CA, CFACFO & Corporate Secretary · b. 1966
  • Mr. Colin BletskyCOO & Director

Financials

Income Statement

Currency: CAD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue012.87K6.48K4.71M398.02K8.29M
Growth (%)---49.65%+72630.36%-91.55%+1981.95%
Cost of Revenue---097.26K7.12M
Gross Profit---4.71M300.75K1.17M
Gross Margin---100.00%75.56%14.13%
Operating Expense---5.52M5.41M7.42M
Operating Income-3.37M-3.01M-5.69M-804.99K-5.11M-6.25M
Operating Margin--23408.97%-87746.92%-17.08%-1284.91%-75.45%
EBITDA---5.56M-804.99K-4.89M-6.89M
EBITDA Margin---85750.50%-17.08%-1228.27%-83.19%
Net Income-3.31M-3.06M-5.57M-676.94K-4.89M-7.26M
Net Income Margin--23808.18%-85905.87%-14.37%-1228.27%-87.58%
R&D149.25K458.38K475.86K857.07K773.86K473.92K
R&D as % of Total Revenue-3561.91%7344.62%18.19%194.43%5.72%
Interest Expense45.87K52.77K10.07K00313.12K
Interest Expense % of Total Revenue-410.02%155.36%0.00%0.00%3.78%

Balance Sheet

Currency: CAD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-3.37M9.70M7.13M6.94M5.42M3.09M
Total Liabilities-1.05M1.25M1.90M1.35M3.25M2.23M
Total Equity-2.32M8.46M5.24M5.58M2.17M867.10K
Cash-3.31M9.62M7.02M6.82M3.00M918.77K

Cash Flow

Currency: CAD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--2.58M-2.41M-3.26M-294.76K-3.58M-5.06M
Financing Cash Flow-1.86M8.72M653.75K95.75K-241.34K4.48M
Capital Expenditure0000000
Free Cash Flow--2.58M-2.41M-3.26M-294.76K-3.58M-5.06M
FCF to OCF-100.00%100.00%100.00%100.00%100.00%100.00%

Earnings

Report DateMay 26, 2022Aug 26, 2022Nov 29, 2022May 26, 2023Aug 28, 2023Nov 29, 2023Dec 31, 2023Apr 23, 2024Aug 28, 2024Nov 26, 2024Dec 31, 2024May 27, 2025Aug 27, 2025Nov 25, 2025Dec 31, 2025Apr 29, 2026Dec 2, 2026
EPS Estimate-0.01-0.02-0.03-0.02-0.02-0.02-0.02-0.02-0.02-0.04-0.02-0.01-0.02-0.04-0.02-0.02-
EPS Actual-0.02-0.03-0.04-0.02-0.02-0.040.070.07-0.02-0.03-0.02-0.03-0.02-0.04-0.03-0.03-
Surprise-100.00%-50.00%-33.33%0.00%0.00%-100.00%450.00%450.00%0.00%25.00%0.00%-200.00%0.00%0.00%-50.00%-50.00%-
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap29.57M
Enterprise Value25.36M
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.11
Price / Book5.79
EPS-0.08
Book Value0.072
Revenue (TTM)9.51M
Gross Profit (TTM)2.24M
EBITDA-4.27M
Profit Margin-58.53%
Operating Margin34.72%
Return on Equity-222.54%
Return on Assets-41.99%
Shares Outstanding70.40M
Shares Float63.10M
Beta0.56
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%